Delaying Skeletal-Related Events in a Randomized Phase 3 Study of Denosumab Versus Zoledronic Acid in Patients with Advanced Cancer: an Analysis of Data from Patients with Solid Tumors
AuthID
P-009-6R3
P-009-6R3